Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-22

Clinical Trial Update: A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150) [Phase 3]

View source ↗

Summary

Phase III study of eszopiclone for insomnia completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lunesta (eszopiclone)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Insomnia | Phase 3 | Status: COMPLETED | Results posted: 2012-11-22